These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15928800)

  • 21. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.
    Valenti L; Varenna M; Fracanzani AL; Rossi V; Fargion S; Sinigaglia L
    Osteoporos Int; 2009 Apr; 20(4):549-55. PubMed ID: 18661088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
    Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
    Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
    Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis.
    Brown MC; Gaffney D; Gemmell C; Oakes E; Morris S; Spooner R; Jardine AG; Geddes CC
    Hemodial Int; 2009 Oct; 13(4):460-6. PubMed ID: 19732172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients.
    Altes A; Ruiz A; Martinez C; Esteve A; Vela MD; Remacha AF; Sarda P; Bach V; Baiget M
    Ann Hematol; 2007 Nov; 86(11):831-5. PubMed ID: 17639389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical significance of HFE gene mutations in patients with iron overload.
    Brandhagen DJ; Fairbanks VF; Baldus WP; Smith CI; Kruckeberg KE; Schaid DJ; Thibodeau SN
    Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
    Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
    Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.